{"id":"di-indolylmethane-dim","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"DIM has been shown to have anti-cancer properties by inhibiting the growth of cancer cells and inducing apoptosis. It also has anti-inflammatory and antioxidant effects.","oneSentence":"DIM is a natural compound that acts as an estrogen receptor antagonist and a weak estrogen receptor agonist.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:09:30.395Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prostate cancer prevention"}]},"trialDetails":[{"nctId":"NCT00212381","phase":"PHASE3","title":"Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia","status":"COMPLETED","sponsor":"New York Presbyterian Hospital","startDate":"2000-09","conditions":"Cervical Dysplasia","enrollment":62},{"nctId":"NCT00784394","phase":"PHASE1","title":"Diindolylmethane in Preventing Cancer in Healthy Volunteers","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-04","conditions":"Healthy, no Evidence of Disease","enrollment":20},{"nctId":"NCT01022333","phase":"PHASE1","title":"The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers","status":"UNKNOWN","sponsor":"Women's College Hospital","startDate":"2009-07","conditions":"Breast Cancer","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"di indolylmethane (DIM)","genericName":"di indolylmethane (DIM)","companyName":"New York Presbyterian Hospital","companyId":"new-york-presbyterian-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DIM is a natural compound that acts as an estrogen receptor antagonist and a weak estrogen receptor agonist. Used for Prostate cancer prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}